glp 1 weight loss timeline Rx Trends: Real-World Data on GLP-1s for ⏳ GLP-1 Progress Timeline —

Tanzeum (Albiglutide) discontinued after FDA warns of risk of anaphylaxis reaction

Asia-Pacific Is the Fastest-Growing Access Region Through 2035 The United States holds a 62.8% GLP-1 Weight Loss Drug Market revenue share in 2026 , driven by the highest commercial drug pricing environment globally

Improved adherence Side effects have been called out as a reason that people stop taking a GLP-1

Diabetologia 47: 18611872

A synthetic version of exendin-4, called exenatide, was approved for medical use by the FDA in 2005

In gastric bypass-operated individuals with obesity and no history of diabetes, GIP(3-30)NH 2 does not affect insulin secretion nor plasma glucose levels (79)